Education and Training
Non-Myeloablative Allogeneic Transplant for Myelodysplastic Syndromes and Myeloproliferative Disorders
To improve survival outcomes for patients with MDS and MPD with a nonmyeloablative allogeneic hematopoietic cell transplant.
Stanford is currently not accepting patients for this trial.
Stanford Investigator(s):
Intervention(s):
- procedure: nonmyeloablative allogeneic hematopoietic cell transplant
Eligibility
Inclusion Criteria:- Myelodysplastic Syndromes
- Myeloproliferative Disorders
- HLA matched donor available Exclusion Criteria:- organ dysfunction
- HIV positive
Ages Eligible for Study
18 Years - 75 Years
Genders Eligible for Study
All
Not currently accepting new patients for this trial
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
BMT Referrals
6507230822
Not Recruiting